PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-05-12

Date Title Company
12-May-2026 Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) Businesswire
12-May-2026 D-Wave Reports First Quarter 2026 Results Businesswire
12-May-2026 Intruder Releases 2026 Attack Surface Management Index: 1 in 4 Organizations Have Exposed MySQL Databases Businesswire
12-May-2026 Glaukos Announces Participation in Upcoming Investor Conferences Businesswire
12-May-2026 IMMEDIATE Therapeutics adds Industry and Scientific Leaders to Advance IMT-358 Breakthrough Ischemic Therapy Businesswire
12-May-2026 Encoded Therapeutics Presents New Preclinical Data at ASGCT 2026 Highlighting Precision Vector Engineering Across Neurology Programs Businesswire
12-May-2026 Serif Biomedicines Presents Data at ASGCT 2026 Demonstrating the Potential of Modified DNA as a New Class of Genetic Medicines Businesswire
12-May-2026 Neurogene Highlights Data at ASGCT Meeting Supporting Therapeutic Rationale for ICV Delivery Method in CNS-targeted Gene Therapy Businesswire
12-May-2026 L&T Technology Services and Emerson Announce a Global Cooperation and Strategic Engagement to Drive Innovation in Engineering Excellence Businesswire
12-May-2026 Glidewell Presents Study on Antimicrobial 3D-Printed Dentures at Antibiotics 2026 Conference in Barcelona ACCESS Newswire
12-May-2026 Infinitopes Appoints Immuno-Oncology Pioneer Jo Brewer as Chief Scientific Officer (CSO) to Advance Therapeutic Pipeline From Clinical to Commercialisation Businesswire
12-May-2026 ACU-Serve Names Natasha Baria Mehta President to Lead Next Phase of Strategic Growth ACCESS Newswire
12-May-2026 Cosmos Health Announces Withdrawal of Registration Statement on Form S-1 ACCESS Newswire
12-May-2026 AI Maverick Intel Issues 76.5 Million Shares to HEAL Group Holdings Under ROFR Agreement ACCESS Newswire
12-May-2026 BioInvent's TNFR2 Antibody BI-1808 Shows Strong Activity and Immune Activation as Single Agent and in Combination with KEYTRUDA(R) (pembrolizumab) in Advanced CTCL (EHA 2026) ACCESS Newswire
12-May-2026 BioInvent to Present Clinical Data on FcγRIIB Antibody BI-1206 Triplet Combination Therapy with rituximab and Calquence(R) in Relapsed/Refractory NHL at EHA 2026 ACCESS Newswire
12-May-2026 Medical Care Technologies (OTC PINK:MDCE) Targets Additional $100K-$200K Asset Monetization Through Infinite Auctions Flash Event ACCESS Newswire
12-May-2026 CEO Statement to Shareholders ACCESS Newswire
12-May-2026 1upHealth Leads Industry in CMS-0057 Readiness with All Health Plan Customers Reporting Ahead of Deadline ACCESS Newswire
12-May-2026 enVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment ACCESS Newswire